Naturally Splendid Announces CANEX Foods As Master Distributor And Initial Purchase Order Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Opdivo as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma Biotech Investing
ROSEN, A TOP RANKED LAW FIRM, Encourages BELLUS Health Inc. Investors with Losses over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
Wellteq Launches Beta Production of Internet of Medical Things HealthHub with API as a Service Biotech Investing
BLU Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Biotech Investing
Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes Biotech Investing
